Found 13 matching trials
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
N/AThis is a non-interventional observational study aiming to evaluate the qua...
Location
Seoul St. Mary Hospital
Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer
PHASE1This example Phase 1 study is designed to evaluate the safety, tolerability...
Location
Peking University Shenzhen Hospital
Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)
PHASE1This example study is an open-label, multi-center, adaptive Phase 1/2 trial...
Location
Peking University Shenzhen Hospital
Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRฮฑ, MUC16)
PHASE1This Phase 1/2 study evaluates the safety, tolerability, and preliminary an...
Location
Peking University Shenzhen Hospital
Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRฮฑ, MUC16) pt2
PHASE1This Phase 1/2 study evaluates the safety, tolerability, and preliminary an...
Location
Peking University Shenzhen Hospital
PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced Solid Tumors
PHASE1This Phase 1/2, open-label, biomarker-guided platform study evaluates the s...
Location
Peking University Shenzhen Hospital
Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
PHASE1This example study evaluates locoregional allogeneic dual-target mesothelin...
Location
Peking University Shenzhen Hospital
Immunotherapy in Lymphoma
N/AThe goal of this observational study is to compare the efficacy of advanced...
Location
Seoul St. Mary Hospital
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)
PHASE1The goal of this Phase I/II observational and interventional platform study...
Location
Multiple Locations
Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma
PHASE1This example study evaluates the safety, tolerability, and preliminary anti...
Location
Peking University Shenzhen Hospital